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According to the American Cancer Society, approximately one in eight women will develop breast cancer during their lifetime. This is why breast cancer screening has 
become so important and why it is being given so much 
attention by healthcare planners. A standardised and evidence-
based protocol for breast cancer screening and breast cancer 
management is needed to optimise treatment outcomes. This 
has been the driving force behind the development of BI-RADS, 
which stands for Breast Imaging Reporting and Data System.
In the past, the medical jargon used for describing imaging 
findings on mammograms, was highly non-standardised 
and was influenced by personal preference. This often led to 
miscommunication and sometimes even mismanagement due to 
misinterpretation of communicated results.
These factors led to efforts that started in the late 1980s 
aimed at standardising mammographic terminology and 
reporting. In 1993, the first edition of the BI-RADS lexicon 
was issued by the American College of Radiology.
The advantages of using BI-RADS are as follows:
• It allows standardised, rational and structured 
analysis of the breast
• Reporting nomenclature is standardised, 
which avoids confusion
• It facilitates communication between breast specialists 
and clinical staff involved in the management of breast 
cancer patients to enhance management
• It facilitates monitoring of treatment outcomes
• It facilitates education of breast care specialists.1
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Fig 1. Breast Type as seen on mammography: a. predominantly fatty breast, 
b. a breast containing scattered fibroglandular elements, c. a heterogeneously 
dense breast, and d. a very dense breast.
The BI-RADS mammography lexicon is presently in its 5th 
edition and it is regularly revised based on experience and learning.2 
Meanwhile, BI-RADS lexicons have also been developed from 
Breast Ultrasound and for Breast MRI, both now in their 2nd edition.
While BI-RADS is mainly 
used by breast care specialists, 
a basic understanding of its 
significance is also important for 
patients and their care-givers. It allows 
them to understand their breast imaging results 
and helps them participate in their treatment.
A standard mammography report should follow a 
standard structure: 
1. It should start with a statement indicating why the 
mammogram is being performed (screening or to follow-up 
a previously detected lesion) and the date/s of the previous 
exam/s to which the present one is being compared.
2. The next statement should indicate the breast type, which 
is classified based on the balance between fatty and fibro-
glandular components into four types: predominantly 
fatty, patchy fibroglandular elements, heterogeneously 
dense breast and very dense breast (Figure 1). Breasts are 
considered very dense if they contain a lot of fibro-glandular 
tissue (>75%) and little fat (Type 4), while they are classified 
as fatty if they contain mostly (> 75%) fat (Type 1). Breast 
density is important for several reasons. Dense breast  tissue 
may increase a woman’s chance of developing breast cancer.3 
Also, detection of breast cancer using mammography is 
more difficult in women with dense breasts. The American 
Cancer Society estimates that approximately 80% of women 
fall in one of the middle two categories, while 10% have fatty 
breasts and another 10% have very dense breasts.
Fig 2. Lesion location reporting must include side, quadrant (upper outer, upper 
inner, lower outer, lower inner), clockface location (e.g. 0700), depth (anterior, 
middle, posterior) and distance from nipple in centimetres.
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3. If an abnormality is noted on a mammogram:
• Its location should be recorded based on laterality, 
quadrant and clockface location, depth and distance 
from the nipple (Figure 2); 
• its characteristics should be described; and
• any change in size or characteristics from previous 
exams must be reported.
4. A BI-RADS classification is then issued based on 
descriptors listed in 3.
5. Finally, Management recommendations are made.
Section 3 in the mammogram report can only occur 
if an abnormality since it involves description of the 
lesion’s characteristics; this forms the basis of the BI-RADS 
classification. BI-RADS scores are as follows:
BI-RADS 0: Need for further imaging or comparison 
with previous exams
BI-RADS 1: No abnormalities
BI-RADS 2: Benign findings
BI-RADS 3: Probably benign but cannot totally exclude 
malignant disease 
BI-RADS 4: Suspicious findings (groups A, B and C based 
on increasing level of suspicion)
BI-RADS 5: Findings strongly suggestive of 
malignant disease
BI-RADS 6: Biopsy-proven breast cancer 
undergoing treatment
Lesion description is a complex exercise as the features being 
analysed often lie along a continuous spectrum of change rather 
than in clearly distinct subgroups. Here are the main lesion 
feature groups defined in the BI-RADS lexicon: 
• Asymmetries: these are densities seen only in one projection or 
lack clear convex border on one projection. They may be focal 
(in less than one quadrant) (Figure 3a) or global (occupying one 
quadrant or more)(Figure 3b). Focal asymmetries are often due 
to tissue superimposition, while global asymmetries are usually 
normal variants. Of more concern is the developing asymmetry, 
which shows growth or change in shape over time; 15% of these 
are cancers (Figure 3c).
• Mass lesions: these are 3-dimensional lesions that are 
clearly seen on 2 projections and that have convex borders. 
They are described based on size, shape (Figure 4) and 
margins (Figure 5), density of nodule (low/intermediate/
high) and associated findings.
• Associated findings: these include calcifications (Figure 6), 
associated distortion (Figure 7), duct changes (Figure 8), 
skin thickening and/or retraction (Figure 9).Figure 3. a. Focal asymmetry (arrow) appears as a denser area in less than one 
quadrant with no clear convex borders; 
this asymmetry was confirmed to be 
normal glandular tissue on ultrasound. 
b. Global asymmetry with the right 
breast containing more fibroglandular 
tissue than the left over an area larger 
than one quadrant; this is frequently 
a normal variant. c. Small asymmetry 
(arrow) noted in an 80 year old woman 
that shows growth and change in shape 
when reviewed 6 months later.
Figure 4: Lesion shape is classified 
into 3 groups: round (a), oval (b) or 
irregular (c). Round and oval lesions 
are mostly benign, while irregular 
lesions raise a high degree of suspicion.
Figure 5: Lesion margins are classified 
into 5 types: circumscribed (a), 
obscured (b), micro-lobulated (c), 
indistinct (d) and spiculated (e). Type a 
represents the lowest level of suspicion, 
while type e represents the highest 
suspicion for malignant disease.
There are many situations 
where there is no clear BI-
RADS score that matches the 
imaging findings. Here are 
some of these situations:
• In very dense breasts 
with no imaging findings 
but poor visibility, one 
must score as BI-RADS 
1. However, one must 
also recommend or proceed to further imaging such as 
ultrasound and in some cases MRI.
• All stable intramammary lymph nodes, benign 
calcifications, fat-containing lesions, implants or metallic 
artefacts, known benign architectural distortion (clear 
stability over time) are classified as BI-RADS 2.
• A score of BI-RADS 3 should be used only if findings are 
almost certainly benign (<2% suspicion). A radiologist 
should not use BI-RADS 3 if he/she is not sure. If a 
radiologist is unsure about a finding (>2% suspicion), 
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Figure 6: Calcifications within a lesion are 
classified based on their shape and size. a. Benign 
type calcifications may have the following features: 
macro (>1mm), central lucency (i), vascular (ii), 
popcorn (iii), rounded and numerous (<1mm) 
(iv), solid rods (v), milk of calcium (vi) and egg-
shell (vii) shape. All aforementioned forms of 
calcification are classified as BI-RADS 2 or 3. 
b. Malignant-appearing calcification are given a 
BI-RADS 4 classification. These include fine linear/
branching/fragmented (i), pleomorphic (mixture 
of appearances) (ii), amorphous (iii) and coarse 
heterogeneous (iv).
Figure 7: Architectural Distortion refers to any distortion of the tissue texture 
lines within the breast (arrow).
Figure 8: A solitary dilated duct 
(arrow) is sometimes seen on 
a mammogram particularly in 
the case of a fatty breast. In the 
absence of associated suspicious 
calcifications, this represents 
<2% risk for malignancy.
a BI-RADS 4A score should be used and further 
investigation recommended; this may involve a follow-
up mammogram or breast ultrasound within 6 months. 
Increase in size of the lesion should prompt biopsy, while 
decrease in size or development of benign features should 
reclassify the lesion to BI-RADS 2. Stable lesions should be 
followed with imaging.
• Unilateral axillary lymphadenopathy that is clearly benign 
based on mammographic findings should be classified as 
BI-RADS 2. If not clearly benign, this finding should be 
given a BI-RADS 0 score and further investigation with 
ultrasound should be performed. One must consider 
the possibilities of an occult breast cancer, lymphoma or 
metastatic carcinoma (such as from melanoma, other skin 
cancer or ovarian cancer).
• Bilateral axillary lymphadenopathy with no breast findings 
should be classified as BI-RADS 2 even if the patient has 
known lymphoma, since the BI-RADS classification is 
based only on findings present in the breast. However, an 
additional statement must be included in the recommended 
management section of the report stating the presence of 
lymphadenopathy and its underlying cause.
• If a patient has had breast cancer resection with positive 
resection margins (i.e. incomplete resection), but 
mammograms show only post-op change, a BI-RADS 
2 score should be used. However, a statement relating 
to surgical resection margins must be included in the 
management statement.
• In a case of clinically evident Paget’s disease of the 
nipple (cancer of the nipple) with no suspicious 
mammographic findings, one must issue a BI-RADS 2 
score and add a statement about the nipple findings in the 
recommendations section.
• BI-RADS 0 scores should be avoided particularly if a 
benign-appearing lesion is present or if further imaging 
with breast MRI is required.
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Figure 9: Spiculated retroareolar lesion (arrows) with associated skin thickening 
(*) due to infiltration of the nipple and adjacent skin.
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The significance of the BI-RADS classification lies in the 
relationship between the BI-RADS score and likelihood of 
malignant disease. The following statistical associations have 
been demonstrated: 
BI-RADS 1 – 0% malignancy
BI-RADS 2 – 0% malignancy 
BI-RADS 3 – 0-2% likelihood of malignancy
BI-RADS 4 – A 2-10% risk; B 11-50% risk; C 51-95% risk
BI-RADS 5 – >95% risk
BI-RADS 6 – Biopsy-proven malignancy under treatment
The BI-RADS classification is one of the main diagnostic 
tools that guides management. Significant discrepancies between 
pathology and BI-RADS reports do sometimes occur, and it is 
often the BI-RADS report that dictates further management 
and not the pathology report as the latter may be influenced by 
sampling errors.
In conclusion, the BI-RADS score and management 
recommendations help the breast radiologist to guide 
treatment and follow-up and ensures accurate communication 
between all breast care specialists. In addition, the BI-RADS 
classification provides a system for structured/systematic 
reporting that is particularly beneficial for training new 
breast radiologists. Finally, a basic understanding of the 
classification helps patients understand and participate in their 
own treatment. 
